Author:
Tang Monica,Lee Chee K.,Lewis Craig R.,Boyer Michael,Brown Bernadette,Schaffer Andrea,Pearson Sallie-Anne,Simes Robert J.
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference43 articles.
1. Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer;Borghaei;N. Eng. J. Med.,2015
2. Nivolumab versus docetaxel in advanced squamous-cell non–small-cell lung cancer;Brahmer;N. Engl. J. Med.,2015
3. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial;Mok;Lancet,2019
4. Pembrolizumab plus chemotherapy in metastatic non–small-cell lung cancer;Gandhi;N. Engl. J. Med.,2018
5. Pembrolizumab plus chemotherapy for squamous non–small-cell lung cancer;Paz-Ares;N. Engl. J. Med.,2018
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献